Developing Playbooks for Rapid Response to Residue Related Deviations Developing Playbooks for Rapid Response to Residue Related Deviations The pharmaceutical industry operates under stringent regulations to ensure product safety, efficacy, and quality. Among the critical aspects of compliance are practices related to residue control and cleaning validation. Residue-related deviations can pose significant risks, leading to enforcement actions such as FDA Form 483 issuance. This article serves as a comprehensive guide, detailing best practices to develop effective playbooks for rapid response to residue-related deviations in the context of regulatory expectations from the FDA, EMA, and MHRA. Understanding the Importance of Residue…